| Manual of industrial microbiology and biotechnology RH Baltz, AL Demain, JE Davies American Society for Microbiology Press, 2010 | 651 | 2010 |
| The SARS-CoV-2 vaccine pipeline: an overview WH Chen, U Strych, PJ Hotez, ME Bottazzi Current tropical medicine reports 7 (2), 61-64, 2020 | 645 | 2020 |
| Correlates and disparities of intention to vaccinate against COVID-19 T Callaghan, A Moghtaderi, JA Lueck, P Hotez, U Strych, A Dor, ... Social science & medicine (1982) 272, 113638, 2021 | 449 | 2021 |
| Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention SM Bartsch, KJ O'shea, MC Ferguson, ME Bottazzi, PT Wedlock, U Strych, ... American journal of preventive medicine 59 (4), 493-503, 2020 | 363 | 2020 |
| Status of vaccine research and development of vaccines for leishmaniasis PM Gillespie, CM Beaumier, U Strych, T Hayward, PJ Hotez, ME Bottazzi Vaccine 34 (26), 2992-2995, 2016 | 221 | 2016 |
| Recombinant protein vaccines, a proven approach against coronavirus pandemics J Pollet, WH Chen, U Strych Advanced drug delivery reviews 170, 71-82, 2021 | 201 | 2021 |
| Neglected tropical diseases among the Association of Southeast Asian Nations (ASEAN): overview and update PJ Hotez, ME Bottazzi, U Strych, LY Chang, YAL Lim, MM Goodenow, ... PLoS neglected tropical diseases 9 (4), e0003575, 2015 | 170 | 2015 |
| Correlates and disparities of COVID-19 vaccine hesitancy T Callaghan, A Moghtaderi, JA Lueck, PJ Hotez, U Strych, A Dor, ... Available at SSRN 3667971, 2020 | 155 | 2020 |
| Serratia marcescens and its extracellular nuclease MJ Benedik, U Strych FEMS microbiology letters 165 (1), 1-13, 1998 | 146 | 1998 |
| Advancing a vaccine to prevent human schistosomiasis M Merrifield, PJ Hotez, CM Beaumier, P Gillespie, U Strych, T Hayward, ... Vaccine 34 (26), 2988-2991, 2016 | 131 | 2016 |
| Characterization of the alanine racemases from two mycobacteria U Strych, RL Penland, M Jimenez, KL Krause, MJ Benedik FEMS microbiology letters 196 (2), 93-98, 2001 | 131 | 2001 |
| The 1.9 Å Crystal Structure of Alanine Racemase from Mycobacterium tuberculosis Contains a Conserved Entryway into the Active Site, P LeMagueres, H Im, J Ebalunode, U Strych, MJ Benedik, JM Briggs, ... Biochemistry 44 (5), 1471-1481, 2005 | 116 | 2005 |
| Optimization of the production process and characterization of the yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1), a SARS vaccine candidate WH Chen, SM Chag, MV Poongavanam, AB Biter, EA Ewere, W Rezende, ... Journal of pharmaceutical sciences 106 (8), 1961-1970, 2017 | 112 | 2017 |
| Label-free, in situ SERS monitoring of individual DNA hybridization in microfluidics J Qi, J Zeng, F Zhao, SH Lin, B Raja, U Strych, RC Willson, WC Shih Nanoscale 6 (15), 8521-8526, 2014 | 101 | 2014 |
| SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice J Pollet, WH Chen, L Versteeg, B Keegan, B Zhan, J Wei, Z Liu, J Lee, ... Human vaccines & immunotherapeutics 17 (8), 2356-2366, 2021 | 90 | 2021 |
| COVID-19 vaccines: neutralizing antibodies and the alum advantage PJ Hotez, DB Corry, U Strych, ME Bottazzi Nature Reviews Immunology 20 (7), 399-400, 2020 | 87 | 2020 |
| Status of vaccine research and development of vaccines for Chagas disease CM Beaumier, PM Gillespie, U Strych, T Hayward, PJ Hotez, ME Bottazzi Vaccine 34 (26), 2996, 2016 | 87 | 2016 |
| Characterization of the Alanine Racemases from Pseudomonas aeruginosa PAO1 U Strych, HC Huang, KL Krause, MJ Benedik Current microbiology 41, 290-294, 2000 | 77 | 2000 |
| Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement WH Chen, X Tao, AS Agrawal, A Algaissi, BH Peng, J Pollet, U Strych, ... Vaccine 38 (47), 7533-7541, 2020 | 75 | 2020 |
| Establishing preferred product characterization for the evaluation of RNA vaccine antigens C Poveda, AB Biter, ME Bottazzi, U Strych Vaccines 7 (4), 131, 2019 | 72 | 2019 |
